ArticlePCN reports : psychiatry and clinical neurosciences2024

Beyond lecanemab: Examining Phase III potential in Alzheimer's therapeutics.

Hitoshi Osaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.